{"corpus_id":26958267,"paper_sha":"236d2f862d045393f93a809a449f5ec9462db5b6","doi":"10.1099/jmm.0.045054-0","arxiv_id":null,"pmid":23180477,"pmcid":null,"mag_id":2110892287,"dblp_id":null,"acl_id":null,"title":"Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options.","year":2013,"publication_date":null,"venue":"Journal of Medical Microbiology","journal":{"name":"Journal of medical microbiology","pages":"\n          10-24\n        ","volume":"62 Pt 1"},"journal_issn":null,"journal_title":null,"publication_types":["Review","JournalArticle"],"pubmed_pub_types":["Journal Article","Review"],"s2_fields_of_study":["Biology","Medicine"],"reference_count":183,"citation_count":1105,"influential_citation_count":52,"is_open_access":false,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Antifungal Agents","mj":false,"qs":[{"q":"classification","mj":false,"ui":"Q000145"},{"q":"therapeutic use","mj":true,"ui":"Q000627"}],"ui":"D000935"},{"d":"Biofilms","mj":true,"qs":[{"q":"drug effects","mj":false,"ui":"Q000187"}],"ui":"D018441"},{"d":"Biological Products","mj":false,"qs":[{"q":"therapeutic use","mj":true,"ui":"Q000627"}],"ui":"D001688"},{"d":"Candida","mj":false,"qs":[{"q":"classification","mj":false,"ui":"Q000145"},{"q":"pathogenicity","mj":false,"ui":"Q000472"},{"q":"physiology","mj":true,"ui":"Q000502"}],"ui":"D002175"},{"d":"Candidiasis","mj":false,"qs":[{"q":"drug therapy","mj":true,"ui":"Q000188"},{"q":"epidemiology","mj":true,"ui":"Q000453"}],"ui":"D002177"},{"d":"Humans","mj":false,"ui":"D006801"}],"chemicals":[{"n":"Antifungal Agents","ui":"D000935","reg":"0"},{"n":"Biological Products","ui":"D001688","reg":"0"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":null,"s2_open_access_landing_url":null,"s2_open_access_license":null,"s2_open_access_status":null,"pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"The incidence of fungal infections has increased significantly, so contributing to morbidity and mortality. This is caused by an increase in antimicrobial resistance and the restricted number of antifungal drugs, which retain many side effects. Candida species are major human fungal pathogens that cause both mucosal and deep tissue infections. Recent evidence suggests that the majority of infections produced by this pathogen are associated with biofilm growth. Biofilms are biological communities with a high degree of organization, in which micro-organisms form structured, coordinated and functional communities. These biological communities are embedded in a self-created extracellular matrix. Biofilm production is also associated with a high level of antimicrobial resistance of the associated organisms. The ability of Candida species to form drug-resistant biofilms is an important factor in their contribution to human disease. The study of plants as an alternative to other forms of drug discovery has attracted great attention because, according to the World Health Organization, these would be the best sources for obtaining a wide variety of drugs and could benefit a large population. Furthermore, silver nanoparticles, antibodies and photodynamic inactivation have also been used with good results. This article presents a brief review of the literature regarding the epidemiology of Candida species, as well as their pathogenicity and ability to form biofilms, the antifungal activity of natural products and other therapeutic options.","claims":[{"public_id":"cl_839ab1a2d109c3dd02600305c511564b","status":"active","text":"Biofilm production is associated with a high level of antimicrobial resistance in the organisms that form it.","confidence":0.9,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_839ab1a2d109c3dd02600305c511564b"},{"public_id":"cl_70385155a7a3be0ed61c731f2e77faa5","status":"active","text":"Drug-resistant biofilm formation is an important factor in the contribution of Candida species to human disease.","confidence":0.88,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_70385155a7a3be0ed61c731f2e77faa5"},{"public_id":"cl_556a95ffe961786ce1d1063f47e877e7","status":"active","text":"Most infections caused by Candida species are associated with biofilm growth.","confidence":0.92,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_556a95ffe961786ce1d1063f47e877e7"},{"public_id":"cl_35946dc9760e75c76a6747c712998f9f","status":"active","text":"Natural products, silver nanoparticles, antibodies, and photodynamic inactivation are presented as antifungal or therapeutic options against Candida species.","confidence":0.86,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_35946dc9760e75c76a6747c712998f9f"}],"concepts":[{"public_id":"co_07c9fe8611b7da19bb3dd135d154b08a","status":"active","name":"antimicrobial resistance","description":"Reduced susceptibility of microorganisms to antimicrobial agents.","types":["phenomenon"],"aliases":["drug resistance"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_07c9fe8611b7da19bb3dd135d154b08a"},{"public_id":"co_226c0ea70445efd052265aba8a02b654","status":"active","name":"drug-resistant biofilms","description":"Biofilms formed by organisms that exhibit resistance to antimicrobial drugs.","types":["phenomenon"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_226c0ea70445efd052265aba8a02b654"},{"public_id":"co_3eef8e260113e4f2da88211d73e06c2e","status":"active","name":"natural products","description":"Plant-derived or other naturally sourced compounds investigated for antifungal activity.","types":["compound class"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_3eef8e260113e4f2da88211d73e06c2e"},{"public_id":"co_6819335031eafb388464520d6b068979","status":"active","name":"infections","description":"Disease states caused by fungal pathogens in mucosal sites or deep tissues.","types":["condition"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_6819335031eafb388464520d6b068979"},{"public_id":"co_8691f5a376850003a399cc14b2e598db","status":"active","name":"biofilm production","description":"The process by which microorganisms generate organized biofilm communities.","types":["process"],"aliases":["biofilm formation"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_8691f5a376850003a399cc14b2e598db"},{"public_id":"co_8c2764ab33f027df7953cd16ac159b41","status":"active","name":"Candida species","description":"A group of fungal species that are important human pathogens causing mucosal and deep tissue infections.","types":["pathogen"],"aliases":["Candida"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_8c2764ab33f027df7953cd16ac159b41"},{"public_id":"co_9420a9553ecc5679de5ad600851e9359","status":"active","name":"silver nanoparticles","description":"Nanoscale particles of silver used here as an antimicrobial therapeutic option.","types":["material"],"aliases":["AgNPs"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_9420a9553ecc5679de5ad600851e9359"},{"public_id":"co_b497eb03f4933ca43c482adf1baab589","status":"active","name":"biofilm growth","description":"The formation of structured microbial communities embedded in a self-produced extracellular matrix.","types":["process"],"aliases":["biofilm formation"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_b497eb03f4933ca43c482adf1baab589"},{"public_id":"co_be6e8b23074272a8d4e2b73389ba6505","status":"active","name":"photodynamic inactivation","description":"A treatment approach that uses light-activated compounds to inactivate microorganisms.","types":["therapeutic approach"],"aliases":["PDI"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_be6e8b23074272a8d4e2b73389ba6505"},{"public_id":"co_f196bbc1df85b0c053bb794da1171f3b","status":"active","name":"human disease","description":"Disease affecting humans, here used to describe the clinical impact of Candida species.","types":["condition"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_f196bbc1df85b0c053bb794da1171f3b"}],"external_ids":{"DOI":"10.1099/jmm.0.045054-0","ArXiv":null,"PubMed":23180477,"PubMedCentral":null,"MAG":2110892287,"DBLP":null,"ACL":null},"open_access":{"is_open_access":false,"pdf_url":null,"landing_url":"https://sah.borca.ai/papers/26958267","source":null,"pdf_url_source":null,"license":null,"reason":"pdf_url_not_indexed"},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":630615,"paper_uid":"71303b46-17b2-40d4-999a-1c1638acbbdc","canonical_identity":{"paper_id":630615,"paper_uid":"71303b46-17b2-40d4-999a-1c1638acbbdc","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/26958267"}